Jean-Michel Cossery
Chairman at SCANCELL HOLDINGS PLC
Net worth: 372 041 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Linda Durrant | F | 67 | 27 years | |
| Sean Murphy | M | 71 |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | 6 years |
| Jurgi Camblong | M | 45 | 13 years | |
| Joshua Jordi | M | - |
EraCal Therapeutics AG
 EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | 6 years |
| Fiona Dunlevy | F | 41 | 9 years | |
| William Daniel | M | 72 | 9 years | |
| Vincent Ossipow | M | 55 | 10 years | |
| Hans Jordi | M | - |
EraCal Therapeutics AG
EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | - |
| Kevin Puylaert | M | - | - | |
| Tomer Berkovitz | M | 44 | 3 years | |
| Marschall Runge | M | 69 | 11 years | |
| Jamere Jackson | M | 54 | 8 years | |
| Rudy Mareel | M | 61 | 6 years | |
| Daan G. M. van Well | M | 49 | 5 years | |
| Ross Muken | M | 44 | 3 years | |
| Troy Cox | M | 60 | 5 years | |
| Ursula Ney | M | 72 | 5 years | |
| Daniel Skovronsky | M | 50 | 6 years | |
| Kieran Murphy | M | 61 |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | 16 years |
| Kirsten Drejer | M | 68 | 4 years | |
| Didier Hirsch | M | 72 | 4 years | |
| Juan Luciano | M | 62 | 8 years | |
| Robert Conley | M | - | 7 years | |
| Andrea Stafford | F | 54 | 2 years | |
| Fayaz Master | M | - | - | |
| Manuela da Silva Valente | F | 54 | 5 years | |
| Philippe Menu | M | 42 | 4 years | |
| Samantha Paston | M | - | 5 years | |
| Susan Clement Davies | F | 62 | 4 years | |
| Peter Casasanto | M | - | 2 years | |
| Abhimanyu Verma | M | - | 2 years | |
| Ken Freedman | M | - | 2 years | |
| Johna Norton | F | 57 | 7 years | |
| Zhenyu Xu | M | 41 | 10 years | |
| Donald Zakrowski | M | - | 12 years | |
| Martin Diggle | M | 62 | 5 years | |
| Sath Nirmalananthan | M | 38 | 1 years | |
| Ita Finegan | F | - | - | |
| Ann Kessler | M | 81 |
EraCal Therapeutics AG
EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | - |
| Chris Pedrick | M | - | 2 years | |
| Lila Tretikov | F | 46 | 1 years | |
| Kathy Hibbs | F | 60 | 3 years | |
| Robert Matthew Miller | M | - | 4 years | |
| George Martin | M | 65 |
Malin Life Sciences Holdings Ltd.
Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | - |
| Mandeep Sehmi | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Lechleiter | M | 70 | 38 years | |
| Adrian Howd | M | 52 | 3 years | |
| Donal O'Connor | M | 73 | 1 years | |
| Neil McLoughlin | M | - | 3 years | |
| Darragh Lyons | M | 43 | 8 years | |
| Carolyn Bertozzi | M | 57 | 4 years | |
| Jeffrey A. Winton | M | - | 3 years | |
| Sally Adams | M | 63 | - | |
| Joshua Smiley | M | 54 | 5 years | |
| Anne Philomena Hyland | F | 64 |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | 6 years |
| Jeffrey Balagna | M | 63 | 1 years | |
| Owen Hughes | M | 49 | 3 years | |
| Antoine Ezell | M | 55 | 20 years | |
| Jennifer Fulk | F | - | 7 years | |
| Simon Sturge | M | 65 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | 2 years |
| Gregory Davis | M | 70 | 20 years | |
| John Dineen | M | 61 |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | 6 years |
| Jackson Tai | M | 73 | 10 years | |
| John Chiplin | M | 66 | 8 years | |
| Robert A. Armitage | M | 75 | 13 years | |
| Jan Lundberg | M | 70 | 8 years | |
| Milton Silva-Craig | M | 56 | 4 years | |
| David Chiswell | M | 70 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | 4 years |
| Kieran McGowan | M | 80 | 3 years | |
| Douglas Oberhelman | M | 71 | 7 years | |
| Franklyn Prendergast | M | 79 | 22 years | |
| Karen N. Horn | M | 80 | 29 years | |
| Robert Alexander Ingram | M | 81 | 3 years | |
| Win Bischoff | M | 81 | 14 years | |
| R. Hoover | M | 77 | 9 years | |
| Derica Rice | M | 59 | 14 years | |
| QI Bo | M | - | 7 years | |
| Zaborowski MaryJo | F | - | 6 years | |
| David Kinard | M | 57 | 21 years | |
| Pascal Qian | M | 56 | 3 years | |
| Scott Jacober | M | - | 18 years | |
| Mary Jane Geiger | M | - | - | |
| Tod Smeal | M | 59 | 5 years | |
| Lori Macomber | F | 53 | 7 years | |
| Wafaa Mamilli | F | 56 | 6 years | |
| Barton Peterson | M | 65 | 8 years | |
| Brian Stuglik | M | 64 | 6 years | |
| J. Ware | M | 71 | 17 years | |
| Richard Gaynor | M | 74 | 14 years | |
| Catherine A. Melfi | M | 64 | 16 years | |
| Sarena S. Lin | F | 53 | - | |
| Catherine Moukheibir | F | 64 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | 2 years |
| Fionnuala M. Walsh | M | 64 | 29 years | |
| Jacques Tapiero | M | 66 | 31 years | |
| Leigh Ann Pusey | F | 61 | 6 years | |
| David M. Kendall | M | 62 | 7 years | |
| Darren J. Carroll | M | - | 4 years | |
| Arnold Hanish | M | 76 | 28 years | |
| Maryjo Chamberlain-Tharp | M | 48 | 17 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 46 | 46.46% |
| Switzerland | 20 | 20.20% |
| United Kingdom | 17 | 17.17% |
| Ireland | 16 | 16.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jean-Michel Cossery
- Personal Network
